Synapse

← Antisense Research and Development

Papers in Antisense Research and Development

Page 1 · newest first

  1. Nuclear Delivery of Antisense Oligodeoxynucleotides Through Reversible Permeabilization of Human Leukemia Cells with Streptolysin OAntisense Research and Development · 1995
  2. Detection of Ribonuclease H-Generated mRNA Fragments in Human Leukemia Cells Following Reversible Membrane Permeabilization in the Presence of Antisense OligodeoxynucleotidesAntisense Research and Development · 1995
  3. Use of Cyclodextrin and Its Derivatives as Carriers for Oligonucleotide DeliveryAntisense Research and Development · 1995
  4. Phosphorothioate Oligonucleotides Reduce Melanoma Growth in a SCID-hu Mouse Model by a Nonantisense MechanismAntisense Research and Development · 1995
  5. Bovine Serum Albumin Is a Major Oligonucleotide-Binding Protein Found on the Surface of Cultured CellsAntisense Research and Development · 1995
  6. Digoxigenin-Labeled Phosphorothioate Oligonucleotides: A New Tool for the Study of Cellular UptakeAntisense Research and Development · 1995
  7. Characterization of Binding Sites, Extent of Binding, and Drug Interactions of Oligonucleotides with AlbuminAntisense Research and Development · 1995
  8. Phosphorothioate Oligonucleotides Cause Degradation of Secretory but Not Intracellular Serglycin Proteoglycan Core Protein in a Sequence-Independent Manner in Human Megakaryocytic Tumor CellsAntisense Research and Development · 1995
  9. (2′-5′)-Oligo-3′-Deoxynucleotides: Selective Binding to Single-Stranded RNA but Not DNAAntisense Research and Development · 1995
  10. 4′-Thio-RNA: Synthesis of Mixed Base 4′-ThioOligoribonucleotides, Nuclease Resistance, and Base Pairing Properties with Complementary Single and Double StrandAntisense Research and Development · 1995
  11. Renal Disposition Characteristics of Oligonucleotides Modified at Terminal Linkages in the Perfused Rat KidneyAntisense Research and Development · 1995
  12. Inhibition of Protein-Tyrosine Kinase Activity in Intact Cells by the Aptameric Action of OligodeoxynucleotidesAntisense Research and Development · 1995
  13. Helix-Stabilizing Compounds CC-1065 and U-71,184 Bind to RNA-DNA and DNA-DNA Duplexes Containing Modified Internucleotide Linkages and Stabilize Duplexes Against Thermal MeltingAntisense Research and Development · 1995
  14. Solution-Phase Synthesis of Phosphorothioate Oligodeoxynucleosides by the Phosphotriester MethodAntisense Research and Development · 1995
  15. Antiviral Activity of an Oligo(nucleoside Methylphosphonate) That Targets HSV-1 Immediate-Early Pre-mRNA 4,5 Is Augmented by Cotreatment with Replication-Defective AdenovirusAntisense Research and Development · 1995
  16. Nonsequence-specific Inhibition of Bacterial Luminescence by Phosphorothioate OligodeoxyribonucleotidesAntisense Research and Development · 1995
  17. The Uptake and Distribution of Phosphorothioate Oligonucleotides into Vascular Smooth Muscle Cells In Vitro and in Rabbit ArteriesAntisense Research and Development · 1995
  18. Influence of Chromosomal Position and Copy Number of a white -Directed Ribozyme Gene on the Suppression of Eye Pigmentation in Drosophila melanogasterAntisense Research and Development · 1995
  19. Cellular Uptake of Oligodeoxyribonucleoside MethylphosphonatesAntisense Research and Development · 1995
  20. Transient Expression Assay for Antisense RNAs Using Episomal Replication of Plasmids: Effective Reduction of Retinoblastoma Gene ( Rb-1 ) Product by Its Antisense RNA Complementary to 3′-Untranslated RegionAntisense Research and Development · 1995
  21. Antiviral Activity of RNA Molecules Containing Self-Releasing Ribozymes Targeted to Lymphocytic Choriomeningitis VirusAntisense Research and Development · 1995
  22. Stability and Pharmacokinetic Characteristics of Oligonucleotides Modified at Terminal Linkages in MiceAntisense Research and Development · 1995
  23. Regulatory Considerations for Oligonucleotide Drugs: Updated Recommendations for Pharmacology and Toxicology StudiesAntisense Research and Development · 1994
  24. Complement Activation and Hemodynamic Changes Following Intravenous Administration of Phosphorothioate Oligonucleotides in the MonkeyAntisense Research and Development · 1994
  25. Reversal of Chemoresistance of Lymphoma Cells by Antisense-Mediated Reduction of bcl -2 Gene ExpressionAntisense Research and Development · 1994
  26. Influence of Base Composition on Membrane Binding and Cellular Uptake of 10-mer Phosphorothioate Oligonucleotides in Chinese Hamster Ovary (CH R C5) CellsAntisense Research and Development · 1994
  27. Further Studies on the Use of Oligonucleotide Facilitators to Increase Ribozyme TurnoverAntisense Research and Development · 1994
  28. Reduction in Replication of the Human Immunodeficiency Virus Type 1 in Human T Cell Lines by Polymerase III-Driven Transcription of Chimeric tRNA—Antisense RNA GenesAntisense Research and Development · 1994
  29. Improved Anti-Herpes Simplex Virus Type 1 Activity of a Phosphodiester Antisense Oligonucleotide Containing a 3′al Hairpin-Like StructureAntisense Research and Development · 1994
  30. Antisense c- myc Oligonucleotide Cellular Uptake and ActivityAntisense Research and Development · 1994
  31. New Insights into the Resistance of α-Oligonucleotides to NucleasesAntisense Research and Development · 1994
  32. αβ Chimeric Antisense Oligonucleotides: Synthesis and Nuclease Resistance in Biological MediaAntisense Research and Development · 1994
  33. Cellular Pharmacology and Protein Binding of Phosphoromonothioate and Phosphorodithioate Oligodeoxynucleotides: A Comparative StudyAntisense Research and Development · 1994
  34. Pharmacokinetics of an Antisense Phosphorothioate Oligodeoxynucleotide against rev from Human Immunodeficiency Virus Type 1 in the Adult Male Rat Following Single Injections and Continuous InfusionAntisense Research and Development · 1994
  35. Interactions of Psoralen-Derivatized Oligodeoxyribonucleoside Methylphosphonates with Vesicular Stomatitis Virus Messenger RNAAntisense Research and Development · 1994
  36. Properties of Exonuclease-Resistant, Psoralen-Conjugated Oligodeoxyribonucleotides in Vitro and in Cell CultureAntisense Research and Development · 1994
  37. Inhibition of HIV-1 Multiplication in a Human CD4 + Lymphocytic Cell Line Expressing Antisense and Sense RNA Molecules Containing HIV-1 Packaging Signal and Rev Response Element(s)Antisense Research and Development · 1994
  38. Selection of Antisense Oligonucleotides on the Basis of Genomic Frequency of the Target SequenceAntisense Research and Development · 1994
  39. Cellular Uptake of Oligodeoxynucleotide Phosphorothioates and Their AnalogsAntisense Research and Development · 1994
  40. Inhibition of T4 Polynucleotide Kinase Activity by Phosphorothioate and Chimeric OligodeoxynucleotidesAntisense Research and Development · 1994
  41. Differential Regulation of Gene Expression in Vivo by Triple Helix-Forming Oligonucleotides as Detected by a Reporter EnzymeAntisense Research and Development · 1994
  42. Intracellular Susceptibility to Ribozymes in a Tethered Substrate—Ribozyme Provirus Model Is Not Predicted by Secondary Structures of Human Immunodeficiency Virus Type 1 RNAs in VitroAntisense Research and Development · 1994
  43. Large-Scale Synthesis, Purification, and Analysis of Oligodeoxynucleotide PhosphorothioatesAntisense Research and Development · 1994
  44. Oligo(A), Oligo(TG), and Alu Repeats of DNA in Chromatin Are Available for Sequence-Specific Chemical Modification with Oligodeoxynucleotide DerivativesAntisense Research and Development · 1994
  45. In Vivo Toxicological Effects of rel A Antisense Phosphorothioates in CD-1 MiceAntisense Research and Development · 1994
  46. Ability of Oligonucleotides with Certain Palindromes to Induce Interferon Production and Augment Natural Killer Cell Activity Is Associated with Their Base LengthAntisense Research and Development · 1994
  47. An Overview of Computer Software Developed to Search Biological Sequence DatabasesAntisense Research and Development · 1993
  48. Inhibition of HIV-1 Replication in Cultured Cells with Antisense Oligonucleotides Encapsulated in ImmunoliposomesAntisense Research and Development · 1993
  49. Comparison of Cellular Binding and Uptake of Antisense Phosphodiester, Phosphorothioate, and Mixed Phosphorothioate and Methylphosphonate OligonucleotidesAntisense Research and Development · 1993
  50. Effects of Sequence of Thioated Oligonucleotides on Cultured Human Mammary Epithelial CellsAntisense Research and Development · 1993